TD Cowen Maintains Buy on MDxHealth, Lowers Price Target to $1.5

Benzinga Newsdesk www.benzinga.com Negative 71.9%

Neg 71.9% Neu 0% Pos 0%

TD Cowen analyst Dan Brennan maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $7 to $1.5.

Comments

No comments yet. Be the first!